Overview
Chart
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Overview
  • Rating
    Not Rated
  • Minimum Investment
    ₹1000
  • NAV (Net Asset Value)
    ₹N/A
  • AUM (Fund size)
    ₹332 Cr
  • Created on
    5 Nov 2025
Fund Ranking
#
/ 16 in Sectoral-Pharma
Risk Level

Very High

Loading...
Returns
Trailing Return
Rolling Return
  • 6 Month
    20.2%
  • 1 Year
    -
  • 3 Year (CAGR)
    -
  • All Time (CAGR)
    13.0%
Category Return
  • 6 Month
    19.9%
  • 1 Year
    17.7%
  • 3 Year (CAGR)
    21.8%
  • All Time (CAGR)
    17.1%
Asset Allocation
  • Equity
    96.0%
  • Other
    4.0%
Top 5 Holdings
Top 5 Sectors
  • Apollo Hospitals Enterprise
    5.64%
  • Astrazeneca Pharma India
    1.26%
  • Aurobindo Pharma
    4.14%
  • Cipla
    6.38%
  • Dr. Reddy's Laboratories
    3.48%
Fund Information
  • Expense Ratio
    2.83%
  • Exit Load
    Exit load of 0.50%, if redeemed within 30 days.
  • Lock-In Period
    No Lock-In

Managed By

Viraj Kulkarni
Nov 2025 - Present
Brijesh Shah
Nov 2025 - Present
Ritika Behera
Nov 2025 - Present
Gaurav Satra
Nov 2025 - Present
Risk & Return Ratio
  • Sharpe Ratio
    0.00
  • Standard Deviation
    0.00
  • Alpha
    0.00
  • Beta
    0.00